article · International Neuropsychiatric Disease Journal
The amygdala, a major limbic structure, regulates emotional response, anxiety, and memory formation. Methamphetamine is known to trigger oxidative stress and neurodegeneration, whereas vitamin A possesses potent antioxidant properties that may offer neuroprotection. This study evaluated the effect of high-dose vitamin A on the amygdala of adult male Wistar rats exposed to toxic doses of methamphetamine. Twenty (20) adults male Wistar rats were randomly assigned into four groups and received as follows: Group A (control), Group B (METH-only; 5 mg/kg at 3-hours interval within 12 hours in a day), group C (Vitamin A-only; 2.5 mg/kg), while, group D (combined METH 5 mg/kg at 3-hours interval within 12 hours in a day + Vitamin A-only; 2.5 mg/kg). All experimental groups received feed and water. The administration was done orally using intubation method for a period of twenty-eight days. Body weight result revealed a significant reduction in the methamphetamine-only group compared with the control suggesting metabolic disturbance and appetite suppression. Co-treatment with vitamin A improved body weight, indicating a restorative metabolic effect. Biochemical findings showed elevated malondialdehyde (MDA) and decreased glutathione (GSH) and superoxide dismutase (SOD) levels in the methamphetamine group, confirming oxidative damage within the amygdala. Vitamin A treatment markedly reduced MDA and preserved GSH and SOD activities, demonstrating enhanced antioxidant defense. Behavioral testing using the Elevated Plus Maze indicated anxiety-related alterations following methamphetamine exposure, while vitamin A co-administration protected these behavioral changes. Histological results showed that methamphetamine caused neuronal degeneration, vacuolation, and necrosis, whereas vitamin A preserved neuronal integrity and promoted partial structural recovery. In conclusion, high-dose vitamin A significantly mitigated methamphetamine-induced oxidative and structural damage in the amygdala, highlighting its antioxidative and neuroprotective potential against psychostimulant toxicity.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.9734/indj/2026/v23i5578
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.